A new cell and gene therapy approach to treat common bleeding disorder
In a new study from the Wake Forest Institute for Regenerative Medicine (WFIRM) researchers have developed an optimized cellular platform for delivering Factor 8 to better treat patients with hemophilia A.
Jul 28, 2020
0
1
